Govt to roll out MSMEs and cluster schemes for strengthening pharmaceuticals Industry
19 Jul 2022
Government of India is planning to roll out a series of initiatives for `Strengthening Pharmaceuticals Industry’ (SPI), with a focus on micro, small and medium enterprises.
Keeping in view the strategic role of MSMEs, which provide important forward and backward linkages to the industry, and also keeping in view that MSMEs tend to grow in clusters, these schemes will address the issues of technology upgradation at both unit level and cluster level.
The government proposes to incentivise the intending MSME units going in for acquiring Schedule M certification or WHO GMP Certification through the sub-scheme Pharmaceuticals Industry Technology Upgradation Assistance Scheme (PTUAS) in order to strengthen the supply chain of Pharmaceutical industry where MSMEs are an integral part.
The MSME unit will have the option to choose from either capital subsidy or interest subvention. At the cluster level, the sub-scheme ‘Assistance to Pharmaceuticals Industry for Common Facilities’ (APICF) envisages support for creation of common facilities like Testing Labs, Common Effluent Treatment plants and other such common facilities by providing government support in the form of capital grant to the extent of up to 70 per cent subject to a ceiling of a maximum of Rs20 crore.
In order to plug the knowledge gap, the third sub-scheme proposes to conduct a series of awareness programmes, conduct sectoral studies and organise similar such programmes to generate soft inputs for policy advocacy.
Union minister of chemicals and fertilizers and health and family welfare Dr Mansukh Mandaviya will formally unveil these initiatives on 21 July 2022 at Dr Bhimrao Ambedkar International Convention Centre.
Senior officials from the Department of Chemicals & Fertilisers, ministry of MSME, SIDBI, NSIC, banks, representatives of industry, start-ups and entrepreneurs are expected to participate.